Recruiting
Phase 1

Selinexor, Carfilzomib, Dexamethasone

Sponsor:

University of Chicago

Code:

NCT02199665

Conditions

Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

selinexor

carfilzomib

dexamethasone

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information